FDgard®
$27.44
Hide Product Info
FDgard® is the #1 Gastroenterologist Recommended herbal product for Functional Dyspepsia (meal-triggered indigestion) 1. FDgard® is a medical food for the dietary management of Functional Dyspepsia (meal-triggered indigestion). FDgard® helps manage the symptoms2 of meal triggered indigestion that occur in the upper belly and include, at varying times and at varying intensities, some or all of the following: Abdominal pain or discomfort, or cramping, difficulty finishing a meal, bloating and nausea.
About the product
FDgard® - The PreMeal Companion®
FDgard® is the #1 Gastroenterologist Recommended herbal product for Functional Dyspepsia (meal-triggered indigestion)3. FDgard® is a medical food for dietary management of Functional Dyspepsia, which utilizes breakthrough science via SST® (Site-Specific Targeting) to deliver caraway oil and l-Menthol quickly and reliably to the upper belly, helping to manage the symptoms4 of meal-triggered indigestion.
FDgard® - The PreMeal Companion®- FDgard® can be used for daily and proactive gut-health support5
- 86% patients reported symptom relief within 2 hours
Usual Adult Dosage: As directed by a physician.
Take two capsules, two times a day. Take 30-60 minutes before meal(s) with water6. If pre-meal dose is missed, FDgard® can be taken when needed. Do not exceed SIX capsules per day. Swallow capsules whole, or open capsules and mix contents with applesauce. Do not chew.
USE UNDER MEDICAL SUPERVISION
1IQVIA ProVoice survey 2020.
2With no known cause
3IQVIA ProVoice survey 2020.
4With no known cause
5Chey WD, Lacy BE, Cash BD, Epstein M, et al. A Novel, Duodenal-Release Formulation of a Combination of Caraway Oil and L-Menthol for the Treatment of Functional Dyspepsia: A Randomized Controlled Trial. Clin Transl Gastroenterol. 2019;10(4) (FDRESTTM, Functional Dyspepsia Response Evaluation and Safety Trial)
6Based on FDREST™, a randomized, placebo-controlled trial of 100 FD patients. Patients taking FDgard experienced a statistically significant reduction versus placebo in postprandial distress syndrome (PDS) (p=0.004) and a near-significant reduction in epigastric pain syndrome (EPS) (p=0.07). Peer-reviewed and published in Clinical and Translational Gastroenterology 2019 10(4), Oral presentation by Dr. William Chey MD, FACG, AGAF, FACP, RFF, University of Michigan. In a real-world patient-reported outcomes trial, FDACT™, showed FDgard efficacy in the first hour. Presented at American College of Gastroenterology Annual Conference 2017; Orlando, FL.
Each capsule contains 25 mg of caraway oil and 20.75 mg of l-menthol. Other ingredients: microcrystalline cellulose, gelatin, metacrylic acid copolymer, metylcellulose, hypromellose, triethyl citrate, croscaramellose sodium, glycerol monostearate, FD&C Red #3, and FD&C Blue #1.